Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole and Breast Density in Postmenopausal Breast Cancer
NCT00244959Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jan 2004
- Primary completion
- Sep 2007
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of anastrozole in breast cancer, sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoint: Change in breast density at 12 months. Started Jan 2004; status: completed.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00244959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244959.